Here's the latest variant picture for Canada, to mid-January.
XFG.* "Stratus" continued to dominate, but fell to 57% frequency.
NB.1.8.1 "Nimbus" grew to 37%.
#XFG
Here's the latest variant picture for the United States, to mid-January.
The XFG.* "Stratus" variant continued it’s dominance, but fell to 71% frequency.
NB.1.8.1 "Nimbus" grew to 15%.
#COVID19 #SARSCoV2 #USA #XFG #Stratus #NB_1_8_1 #Nimbus
Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20USA.pdf
🧵 ends
Here's the latest variant picture for New Zealand, to late January.
In a chaotic scene, NB.1.8.1 "Nimbus", JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus" are all significant. This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
BA.3.2.* "Cicada" is also present, but at only 11%.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20NZ.pdf
Here's the latest variant picture for Canada, to mid-January.
XFG.* "Stratus" continued to dominate, but fell to 60% frequency.
NB.1.8.1 "Nimbus" grew to 33%.
Here's the latest variant picture for the United States, to mid-January.
The XFG.* "Stratus" variant continued it’s dominance, falling slightly to 74% frequency.
NB.1.8.1 "Nimbus" was roughly flat at 12%.
Here's the latest variant picture for New Zealand, to mid-January.
In a chaotic scene, NB.1.8.1 "Nimbus", JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus" are all significant. This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
BA.3.2.* "Cicada" is also present, but at only 8%.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
Here's the latest variant picture for Europe (excluding the UK), to early January.
BA.3.2.* "Cicada" showed a steady growth advantage of 7% per day (49% per week) over XFG.* "Stratus", with a crossover in late December.
Here's the latest variant picture for Canada, to early January.
XFG.* "Stratus" continued to dominate, growing slightly to 64% frequency.
NB.1.8.1 "Nimbus" fell to 27%.
Here's the latest variant picture for the United States, to early January.
The XFG.* "Stratus" variant continued it’s dominance, falling slightly to 78% frequency.
NB.1.8.1 "Nimbus" grew slightly to 11%.
Here's the latest variant picture for New Zealand, to mid-January.
In a chaotic scene, NB.1.8.1 "Nimbus", JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus" are all significant. This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
BA.3.2.* "Cicada" is also present, but at low frequencies so far.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20NZ.pdf
Here's the latest variant picture for the United States, to late December.
The XFG.* "Stratus" variant continued it’s dominance, finishing at 82% frequency.
NB.1.8.1 "Nimbus" was roughly flat at 9%.
Here's the latest variant picture for New Zealand, to early January.
In a chaotic scene, NB.1.8.1 "Nimbus" is being challenged by JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus". This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
BA.3.2.* "Cicada" is also present, but at low frequencies so far.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
@RoteBlume
90% #XFG sind beeindruckend. Ich dachte unsere 60% sind viel.
Here's the latest variant picture for Europe (excluding the UK), to the end of November.
BA.3.2.* "Cicada" showed a slightly slowing growth advantage of 7% per day (49% per week) over XFG.* "Stratus", which predicts a crossover in late December.
Here's the latest variant picture for Canada, to the end of November.
XFG.* "Stratus" continued to dominate, up slightly to 73%.
NB.1.8.1 "Nimbus" also rose, to 23%.
#COVID19 #SARSCoV2 #Canada #XFG #Stratus #NB_1_8_1 #Nimbus
🧵
Here's the latest variant picture for the United States, to the end of November.
The XFG.* "Stratus" variant continued it’s dominance, but fell to 81% frequency.
NB.1.8.1 "Nimbus" was up slightly to 9%.
Here's the latest variant picture for New Zealand, to early December.
In a chaotic scene, NB.1.8.1 "Nimbus" is being challenged by JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus". This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
🧵
Here's the latest variant picture for Europe (excluding the UK), to late November.
BA.3.2.* "Cicada" is showing a very strong growth advantage of 7.9% per day (55% per week) over XFG.* "Stratus", which predicts a crossover in late December.
To include the latest BA.3.2.* samples, I have rolled my reporting window forward an extra week or so. So the most recent data is even less representative than usual. The picture for those dates might change as more data is shared.
Here's the latest variant picture for Canada, to late November.
XFG.* "Stratus" continued to dominate, but fell to 67%.
NB.1.8.1 "Nimbus" rose slightly to 18%.
XFV.* grew to 10% nationally, however all the recent samples are from Ontario and recent volumes are very low, so that could just be a cluster from a healthcare or aged care setting.
#COVID19 #SARSCoV2 #Canada #XFG #Stratus #NB_1_8_1 #Nimbus #FLiRT
🧵
Client Info
Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst